company background image
VTI

Visioneering Technologies ASX:VTI Stock Report

Last Price

AU$0.30

Market Cap

AU$9.4m

7D

0%

1Y

-67.2%

Updated

27 Nov, 2022

Data

Company Financials
VTI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

VTI Stock Overview

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific.

Visioneering Technologies, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Visioneering Technologies
Historical stock prices
Current Share PriceAU$0.30
52 Week HighAU$1.05
52 Week LowAU$0.20
Beta1.57
1 Month Change13.21%
3 Month Change-3.23%
1 Year Change-67.21%
3 Year Change-95.52%
5 Year Change-99.17%
Change since IPO-99.33%

Recent News & Updates

Recent updates

Health Check: How Prudently Does Visioneering Technologies (ASX:VTI) Use Debt?

Sep 23
Health Check: How Prudently Does Visioneering Technologies (ASX:VTI) Use Debt?

Shareholder Returns

VTIAU Medical EquipmentAU Market
7D0%1.0%1.2%
1Y-67.2%-12.0%-2.9%

Return vs Industry: VTI underperformed the Australian Medical Equipment industry which returned -12% over the past year.

Return vs Market: VTI underperformed the Australian Market which returned -2.9% over the past year.

Price Volatility

Is VTI's price volatile compared to industry and market?
VTI volatility
VTI Average Weekly Movement16.9%
Medical Equipment Industry Average Movement10.5%
Market Average Movement9.0%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market4.2%

Stable Share Price: VTI is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 17% a week.

Volatility Over Time: VTI's weekly volatility has increased from 11% to 17% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008n/an/ahttps://www.vtivision.com

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. The company’s flagship product comprises NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. Visioneering Technologies, Inc. was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Visioneering Technologies, Inc. Fundamentals Summary

How do Visioneering Technologies's earnings and revenue compare to its market cap?
VTI fundamental statistics
Market CapAU$9.40m
Earnings (TTM)-AU$5.93m
Revenue (TTM)AU$11.51m

0.8x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VTI income statement (TTM)
RevenueUS$7.76m
Cost of RevenueUS$6.95m
Gross ProfitUS$816.00k
Other ExpensesUS$4.82m
Earnings-US$4.00m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.13
Gross Margin10.51%
Net Profit Margin-51.56%
Debt/Equity Ratio38.5%

How did VTI perform over the long term?

See historical performance and comparison